Some Cancer Patients 'Hyperprogress' on Immunotherapy

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens. Nature 2014; 515: 577-581 [PMID: 25428507 DOI: 10.1038/nature13988] 38 Lu YC, Yao X, Crystal JS, Li YF, El-Gamil M, Gross C, Davis L, Dudley ME, Yang JC, Samuels Y, Rosenberg SA, Robbins PF. ................
................